{"response": {"meta": {"time": 15, "hits": 2, "offset": 0}, "docs": [{"news_desk": "Business/Financial Desk", "document_type": "article", "_id": "4fd23f1f8eb7c8105d7d64ff", "headline": {"main": "F.D.A. Failing In Drug Safety, Official Asserts"}, "pub_date": "2004-11-19T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By GARDINER HARRIS", "person": [{"lastname": "HARRIS", "rank": 1, "firstname": "Gardiner", "organization": "", "role": "reported"}]}, "abstract": "FDA drug safety reviewer Dr David Graham tells Senate Finance Committee that regulators are 'virtually incapable of protecting America' from unsafe drugs and names five drugs now on market that should be 'seriously looked at'; Graham, twenty-year FDA veteran, denounces FDA as feckless and apt to surrender to drug makers, and fears 'drug safety catastrophe'; FDA drug evaluator Dr Steven Galson calls Graham's data irresponsible and deputy dir Dr Sandra Kweder says five drugs he cites are not 'more concerning than any others'; Graham questions cholesterol drug Crestor, pain pill Bextra, obesity pill Meridia, asthma drug Serevent and acne drug Accutane; all are defended by manufacturers; photo; chart on five drugs; panel chairman Charles Grassley is focusing on Merck's withdrawal of arthritis drug Vioxx after study found that heart attack risk doubles after 18 months of use; FDA critics say drug should have pulled much earlier, after 1999 and 2000 studies showed risk (M)", "web_url": "http://www.nytimes.com/2004/11/19/business/19fda.html", "section_name": "Front Page; Health; Business", "lead_paragraph": "Federal drug regulators are ''virtually incapable of protecting America'' from unsafe drugs, a federal drug safety reviewer told a Congressional panel on Thursday, and he named five drugs now on the market whose safety needs ''to be seriously looked at.'' In testimony before the Senate Finance Committee, Dr. David Graham, the reviewer in the Food and Drug Administration's Office of Drug Safety, used fiery language to denounce his agency as feckless and far too likely to surrender to demands of drug makers.", "snippet": "Federal drug regulators are \"virtually incapable of protecting America\" from unsafe drugs, a federal drug safety reviewer told a Congressional panel.", "blog": [], "keywords": [{"value": "GRASSLEY, CHARLES E", "name": "persons"}, {"value": "GRAHAM, DAVID", "name": "persons"}, {"value": "GALSON, STEVEN", "name": "persons"}, {"value": "KWEDER, SANDRA", "name": "persons"}, {"value": "FOOD AND DRUG ADMINISTRATION", "name": "organizations"}, {"value": "MERCK & CO INC", "name": "organizations"}, {"value": "HEART", "name": "subject"}, {"value": "BEXTRA (DRUG)", "name": "subject"}, {"value": "ACCUTANE (DRUG)", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "ARTHRITIS AND RHEUMATISM", "name": "subject"}, {"value": "CRESTOR (DRUG)", "name": "subject"}, {"value": "SKIN", "name": "subject"}, {"value": "CONSUMER PROTECTION", "name": "subject"}, {"value": "REGULATION AND DEREGULATION OF INDUSTRY", "name": "subject"}, {"value": "RECALLS AND BANS OF PRODUCTS", "name": "subject"}, {"value": "MERIDIA (DRUG)", "name": "subject"}, {"value": "BIRTH DEFECTS", "name": "subject"}, {"value": "ACNE", "name": "subject"}, {"value": "WEIGHT", "name": "subject"}, {"value": "ASTHMA", "name": "subject"}, {"value": "BLOOD", "name": "subject"}, {"value": "MEDICINE AND HEALTH", "name": "subject"}, {"value": "SEREVENT (DRUG)", "name": "subject"}, {"value": "CHOLESTEROL", "name": "subject"}, {"value": "VIOXX (DRUG)", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 1523, "subsection_name": null, "multimedia": [{"legacy": {"thumbnailheight": 75, "hasthumbnail": "Y", "thumbnail": "images/2004/11/19/business/19fda.751.jpg"}, "height": 75, "type": "image", "url": "images/2004/11/19/business/19fda.751.jpg", "subtype": "thumbnail"}]}, {"news_desk": "Foreign Desk", "document_type": "article", "_id": "4fd254e58eb7c8105d7fcde2", "headline": {"main": "England's Smoky Pubs Could Erelong Be Smoky No More"}, "pub_date": "2004-11-17T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By ALAN COWELL", "person": [{"lastname": "COWELL", "rank": 1, "firstname": "Alan", "organization": "", "role": "reported"}]}, "abstract": "English pubs, which evoke time-hallowed image of low beams, warm ales and toxic tobacco smog, may become next smoke-free public places, as they are already or will be soon in Scotland, Ireland, New York and Norway; Prime Min Tony Blair proposes near-total ban on smoking in workplaces, restaurants and pubs that serve food, although not in private clubs or bars that do not serve food and cater mostly to blue-collar drinkers (M)", "web_url": "http://www.nytimes.com/2004/11/17/international/europe/17britain.html", "section_name": "World", "lead_paragraph": "By time-hallowed tradition, the English pub evokes an image of low beams, warm ales and the toxic swirling smog of tobacco smoke. But not, perhaps, for much longer. In proposals put before Parliament on Tuesday, the government of Prime Minister Tony Blair said it would seek a near-total ban on smoking in workplaces, restaurants and pubs that serve food. The prohibition, which follows similar actions by the authorities in places including Ireland and Scotland, New York and Norway, would be phased in between 2006 and 2008.", "snippet": "The government said it would seek a near-total ban on smoking in workplaces, restaurants and pubs that serve food.", "blog": [], "keywords": [{"value": "BLAIR, TONY", "name": "persons"}, {"value": "NEW YORK CITY", "name": "glocations"}, {"value": "IRELAND", "name": "glocations"}, {"value": "GREAT BRITAIN", "name": "glocations"}, {"value": "SCOTLAND", "name": "glocations"}, {"value": "NORWAY", "name": "glocations"}, {"value": "BARS", "name": "subject"}, {"value": "RESTAURANTS", "name": "subject"}, {"value": "POLITICS AND GOVERNMENT", "name": "subject"}, {"value": "LAW AND LEGISLATION", "name": "subject"}, {"value": "SMOKING AND TOBACCO", "name": "subject"}], "print_page": "7", "type_of_material": "News", "word_count": 541, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}